|
Valvular Heart Disease |
Dopamine Agonists and the Risk of Cardiac Valve Regurgitation
-Study Overview by Dr. Rene Schade et al (2007)
RAAVE: Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progressions of Aortic Stenosis
-Trial Overview by Dr. Luis M. Moura et al (2007)
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease
-Study Overview by Dr. Renzo Zanettini et al (2007)
Who Are We? Slide
Downloading Policy
Financial Disclosure
We Do Not
Promote Off Label Product Use
Copyright
Source of Slides
Editorial Policy
Links Policy
Privacy
Policy
Access
CME Programs
© 1999-2009 by
Clinical Trial Results .org. None of the materials on this website may be
reproduced, modified, distributed, transmitted, republished, displayed, or
performed unless prior written approval is obtained by Clinical Trial Results.
All such requests should be forwarded to Susan J. Marble at
smarble@clinicaltrialresults.org. For further information please see the
Policy section.
Webmaster